Results 221 to 230 of about 78,358 (306)

Artificial Intelligence Enabled Noninvasive Mapping of Cardiac Arrhythmia Origins Using the 12-Lead Electrocardiogram. [PDF]

J Cardiovasc Electrophysiol
Antoun I, Alkhayer A, Abdelrazik A, Eldesouky M, Thu KM, Ibrahim M, Somani R, André Ng G.   +7 more
europepmc   +1 more source

Pulsed-Field Ablation in Adult Congenital Heart Disease: Promise, Prudence, and the Path Forward. [PDF]

JACC Case Rep
Aronis KN.
europepmc   +1 more source

Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross‐sectional comparative echocardiographic study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective While cardiometabolic comorbidities have been well established in adults with polycystic ovary syndrome (PCOS), it remains unclear whether the early signs of cardiovascular morbidity emerge during adolescence. This study aimed to investigate whether metabolic and cardiovascular alterations begin in adolescents with PCOS.
Demet Aygün Ari, Melis Pehlivantürk Kizilkan, Musa Öztürk, İlker Ertuğrul, Hayrettin Hakan Aykan, Tevfik Karagöz, Nuray Kanbur, Orhan Derman, Sinem Akgül   +8 more
wiley   +1 more source

Predicting sudden cardiac death in heart failure with reduced ejection fraction. [PDF]

Heart Fail Rev
Mkrtchyan N, Akram A, Dixit N, Hajduczok A, Birs A.   +4 more
europepmc   +1 more source

Mapping the Global Clinical Landscape of Pharmacological Therapies for Heart Failure With Preserved Ejection Fraction: An Analysis Based on ClinicalTrials.gov (2003–2025)

iMetaMed, EarlyView.
This study analyzed 236 heart failure with preserved ejection fraction (HFpEF) pharmacological trials registered on ClinicalTrials.gov from 2003 to 2025, revealing a post‐2016 surge (76.3%), U.S. dominance (58.5%), and prominence of SGLT2 inhibitors/novel therapies (each 13.1%).
Yucheng Hou, Jingwei Zhao, Yuqian Tang, Tan Liu, Zhiao Zhang, Ziheng Wang, Han Shen   +6 more
wiley   +1 more source

Refractory ventricular tachycardia storm with 42 ICD shocks in 24 h: A case report. [PDF]

Med Int (Lond)
Adrejiya P, Neshat N, Qamar AR, Suthar H, Orjioke N, Thandra A, Patel D.   +6 more
europepmc   +1 more source

The Role and Therapeutic Potential of Voltage‐Gated Potassium Channel Kv1.3 in Metabolism‐Related Disorders

iNew Medicine, EarlyView.
ABSTRACT Over the past three decades, the global burden of common metabolic diseases such as obesity, diabetes, and atherosclerosis has steadily increased, becoming a serious public health issue that poses a major threat to human health worldwide. Potassium channels, particularly the voltage‐gated Kv1.3 subtype, serve as critical regulators of cellular
Wenjun Zhen, Junda Liu, Xixi Chen, Shi Chen, Yuanyuan Tian, Baoming Wu, Fengxia Yan   +6 more
wiley   +1 more source

First-in-human experience for cardiac arrhythmia mapping using a novel ultra-high-density globe-shaped catheter from the multicenter COSMOS study. [PDF]

Heart Rhythm O2
Anic A, Grimaldi M, De Potter T, de Asmundis C, Chierchia GB, Quadrini F, di Monaco A, Brešković T, Mansour M, Nakagawa H, Almorad A.   +10 more
europepmc   +1 more source

Vascular Calcification: Mechanisms, Models, and Therapies

iNew Medicine, EarlyView.
ABSTRACT Vascular calcification represents an active multifactorial process that mirrors several key features of skeletal bone mineralization. Clinically, it is characterized by diminished arterial compliance and increased arterial wall stiffness, both of which serve as independent predictors of significant adverse cardiovascular events.
Wenya Zhu, Shu Yang, Ziyi Chen, Xiaoxiao Yang, Zhen Liang, Yuanli Chen   +5 more
wiley   +1 more source

From Beat to Risk: How Heart Rate Variability Predicts Arrhythmias in Type 2 Diabetes. [PDF]

Life (Basel)
Bobu AM, Duca ȘT, Cucu AI, Avieriței DA, Ponor CG, Cepoi MR, Cucută S, Dmour BA, Costea CF, Botnariu G, Costache-Enache II.   +10 more
europepmc   +1 more source